Dr. Miguel Cordero

Clínica Oftalmológica León Ocular > Dr. Miguel Cordero

Back To Homepage
Médico Oftalmólogo

Dr. Miguel Cordero

doctor-miguel-cordero-oftalmologo-en-leon

Oftalmólogo a cargo de la Unidad de Uveítis. Servicio de Oftalmología. Hospital Universitario de León. (León, España). Investigador asociado del IBIOMED, Universidad de León (León, España). Socio fundador y actual tesorero de la Sociedad Española de Inflamación Ocular (SEIO). Miembro de la Sociedad Española de Oftalmología (SEO) y de la Academia Americana de Oftalmología (AAO). Miembro electo de la Sociedad Americana de Uveítis (AUS). Miembro de la Sociedad Foster de Inmunología Ocular (FOIS). Miembro de la Sociedad Internacional de Inflamación Ocular (IOIS). Miembro del consejo editorial de Journal of Ophthalmology. Revisor de numerosas revistas oftalmológicas internacionales como Eye, Molecular Vision, Opthalmic genetics etc. Investigador principal en varios ensayos clínicos internacionales de tratamientos para la uveitis. Miembro del comité editorial de la Sociedad Española de Oftalmología.

Titulaciones

Licenciado en Medicina

Especialista en Oftalmología vía MIR

Subespecialidad en Glaucoma y Cirugía de Glaucoma

Doctor en Medicina. Tesis doctoral titulada: “Estudio clínico e inmunológico de la acción de Adalimumab en el tratamiento de las uveitis inmunomediadas refractarias”.

Formación Investigadora

Fellow of the European Board of Ophthalmology (FEBO) (Ir a la web)

Cursos de Doctorado del Departamento de Anatomía de la Universidad de Salamanca

Suficiencia investigadora por el Departamento de Anatomía de la Universidad de Salamanca (Ir a la web)

Fellow of the European Board of Ophthalmology (FEBO) (Ir a la web)

doctor-miguel-cordero-oftalmologo-leon-congreso-2013
El Dr Cordero durante su intervención en el congreso de la Sociedad Americana de Oftalmología (AAO) del 2013 en Nueva Orleans, USA.
doctor-miguel-cordero-oftalmologo-leon-congreso-uveitis
El Dr Cordero durante su intervención en el reciente congreso internacional de uveítis de Barcelona.

Presentaciones en congresos

2003

Ophthalmologic Manifestations of Ulcerative Colitis: Case Study”. (Comunication in panel). Cordero Coma M. 79th Congress of the Spanish Society of Ophthalmology.(S.E.O.).Valencia, Spain

”Cataract Surgery in Small Pupil Eye” (Video). Franco M, Mateos A, Alonso JL, Cordero Coma M. X Congress of the European Society of Cataract and Refractive Surgeons (ESCRS). Munich, Germany

”¿Where are the Vessels of the Optic Nerve? (Contest of Scientific Photography). Cordero Coma M. National Conference for Ophthalmology Residents. Valencia, Spain,

“Optic-Ischemic Neuropathy after Surgery of the Lumbar Spine” (Communication in panel). Cordero Coma M, Mateos Hernández A, Franco M. National Conference for Ophthalmology Residents. Valencia, Spain

“Post-Surgical Endophthalmitis: Current situation”. Mateos Hernández A, Cordero Coma M. 79th Congress of the Spanish Society of Ophthalmology (S.E.O.).Valencia, Spain

2004

”Tuberculous Uveitis: A Growing Pathology? A. Mateos, M. Franco, M. Cordero. Seminar of Ophthalmology. (University of Oviedo). Oviedo, Spain, October

”Mooren’s Ulcer and Use of Amniotic Membrane”. A. M. Hernández, M. Franco, M. Cordero Coma. 80th Meeting of the Spanish Society of Ophthalmology (S.E.O.). Valencia, Spain.

2005

”Post-ICL Phacoanaphylactic Uveitis: Case Study”. 18th Meeting of the Inter-Hospital Uveitis Group (GEMU). Madrid, Spain

2006

“Systemic Immunomodulatory therapy in severe dry eye secondary to dacryoadenitis”. Cordero Coma M, Anzaar F, Sobrin L, Foster CS. Meeting of the Association for Research in vision and Ophthalmology (ARVO). Presented 04/30/2006. Fort Lauderdale, Fl (USA).

“A Case of Vogt-Koyanagi-Harada Sindrome”. Yilmaz T., Cordero Coma M, Onal S, Teasley LA, Foster CS. International Conference of Ophthalmic Photography. Presented 5/18/2006. San Francisco, CA (USA).

“A Case of Sytemic Lupus Erythematosus-Associated Choroidopathy”.Yilmaz T, Cordero Coma M, Sobrin L., Foster CS. International Conference of Ophthalmic Photography. Presented n 5/18/2006. San Francisco, CA (USA).

2007

“Systemic Immunomodulatory therapy for severe dry eye”. Anzaar F, Cordero Coma M, Sobrin L, Foster CS. American Academy of Ophthalmology. Las Vegas, Nv (USA).

“A Case of Sytemic Lupus Erythematosus-Associated Choroidopathy”.Yilmaz T, Cordero Coma M, Sobrin L., Foster CS. Ophthalmic Photographer´s Society. Presented in October 2006. Las Vegas, NV (USA).

“A Case of Vogt-Koyanagi-Harada Sindrome”. Yilmaz T., Cordero Coma M, Onal S, Teasley LA, Foster CS. Ophthalmic Photographer´s Society. Presented n October 2006. Las Vegas, NV (USA).

“VKH: Treatment with Infliximab”. Cordero Coma M, FrancoM, García JM. 20th Meeting of the Inter-Hospital Uveitis Group(GEMU).. Madrid, Spain.

“Intravitreal Bevacizumab for uveitic macular edema”. CorderoComa M. Seminar of Ophthalmology. (University of Oviedo). Oviedo, Spain.

2008

“Infliximab & Serpiginous Choroiditis: Death alter disseminated tuberculosi”. Miguel Cordero, Hospital de León, León. 21a Reunión del Grupo Español Multicéntrico de Uveítis (GEMU).. Madrid

“Intravitreal Triamcinolone Acetonide for the Treatment of Refractory Diabetic Macular Edema: An Evidence-Based Systematic Review”. T. Yilmaz, C. Weaver, M. Cordero-Coma, M.J. Gallagher, R.A. Cervantes-Castaneda, R.J. Larson. Meeting of the Association for Research in vision and Ophthalmology (ARVO). Presentado 04/30/2008. FortLauderdale,Fl(USA).

“Silicon Tamponade in the management of chronic post-surgical endophthalmitis resistant to treatment”. Miguel Cordero Coma, Carlos Lobato Fuertes. LXXXIV Congreso of the Spanish Society of Ophthalmology. 24-27/09/2008. Sevilla (Spain).

”New therapeutic alternatives for macular edema in uveitis”. Miguel Cordero Coma, Elena Pérez Díez. XVI Meeting of the Castellano-Leonesa Society of Ophthalmology. 15/11/2008. Palencia (Spain).

“New diagnostic approach in Tuberculous Uveitis” Manuel Franco Benito, Miguel Cordero Coma. XXV Aniversary of the Ophthalmology Department at the Hospital Central de Asturias. 21 y 22/11/2008. Oviedo (Spain)

2009

“Use of Adalimumab in Mooren´s Ulcer”. Carlos Lobato Fuertes, Miguel Cordero-Coma, Manuel Franco Benito, JM García Ruíz de Morales. 22th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia

“Ocular Sarcoidosis: Study of 42 cases”. Elena Pérez Díez, M Cordero Coma, M Franco, JM García Ruíz de Morales. 22th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia

“Infectious screening in Uveitis: Is it possible to completely rule-out?”. Miguel Cordero Coma. First Meeting of the Uveitis Units from the North of Spain. San Sebastian

“Uveitis & Sarcoidosis”. Elena Pérez, Esther Rodríguez, Miguel Cordero. M. Seminar of Ophthalmology. (University of Oviedo). Oviedo, Spain.

“New Emerging Therapies in Uveitis”. Miguel Cordero. Annual Meeting of the Ophthalmologic Society of Madrid. Madrid

2010

“Posterior scleritis and refractory macular edema”. Carlos Lobato, M Cordero. 23th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia

“Birdshot & negative HLA-B29”. Esther Rodríguez, M Cordero. 23th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia

“Relapsing Toxoplasmosis vs secondary neovascular membrane”. Elena Pérez, M Cordero. 23th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia

“Adalimumab therapy for refractory uveitis: A multicenter study”. Manuel Díaz-Llopis, David Salom, M Cordero. 1st World Congress on Controversies in Ophthalmology. Prague, Czech Republic.

“Does geographic location (urban versus rural) or insurance status affect the likelihood of receiving a cataract diagnosis?. Gallagher MJ, Yilmaz T, Padula WV, Cordero-Coma M. Meeting of the Association for Research in vision and Ophthalmology (ARVO). 2010. FortLauderdale, Fl(USA).

“Use of Control Charts to Monitor Post-Cataract Surgery Endophthalmitis in Spain”. M Cordero. Meeting of the Association for Research in vision and Ophthalmology (ARVO). 2010. FortLauderdale, Fl(USA).

“Adalimumab therapy for refractory uveitis: A multicenter study”. Manuel Díaz-Llopis, David Salom, M Cordero. Meeting of the Association for Research in vision and Ophthalmology (ARVO). 2010. FortLauderdale, Fl(USA).

“ Utility of an in-vitro test for interferon gamma production in response to M. Tuberculosis in chronic posterior uveitis patients”. S Calleja, M Cordero. 35th Congress of the Spanish Immunology Society. San Sebastián, Spain

“Adalimumab therapy for refractory uveitis: A multicenter study”. Manuel Díaz-Llopis, David Salom, Gabriela Ortega, M Cordero, J. Carlos Fernández Cid, Miguel Cordero. World Ophthalmology Congress 2010. ICC, Berlín, Germany.

“Serpiginous Choroiditis: Activity parameters”. M Cordero. 86th Meeting of the Spanish Society of Ophthalmology (S.E.O.). Madrid, Spain

“Punctate Inner Choroidopathy and systemic Leptospira Interrogans infection: A new association? B Martín, M Cordero. 86th Meeting of the Spanish Society of Ophthalmology (S.E.O.). Madrid, Spain

2011

“Uveitis and Tuberculosis”. M Cordero. V Congress of the AADEA. Jaén, Spain.

“Systemic Erythematosus Lupus and Antiphospholipid syndrome”. Rodríguez E, Cordero-Coma M. 24th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia

“Screening of multiple sclerosis in patients with intermediate uveitis: Is it necessary?. Martín-Escuer B, Cordero-Coma M. 24th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia.

“Efficacy of combined cyclosporine A and mycophenolate mofeil in the treatment of patients with Birdshot retinocoroidopathy: A 12-month follow-up”. González LA, Cervantes-Castañeda RA, Cordero-Coma M. Meeting of the Association for Research in vision and Ophthalmology (ARVO). 2011. FortLauderdale, Fl (USA).

“More common infectious uveitis: New diagnostic advances”. Cordero-Coma M. Lecture. XV Meeting of the Vitreo-Retinal Spanish Society. Madrid

“Serpiginous choroiditis” in: “Clinical Cases: Presentation and discussion.” Conference at Seminar of Ophthalmology. (University of Oviedo). Oviedo, Spain.

“Adalimumab in refractory uveitis: A multicenter sudy of 132 cases”. 29th Congress of the Pan-American Association of Ophthalmology. Buenos Aires, Argentina.

“Serpiginous choroiditis” in: “Clinical Cases: Presentation and discussion.” Conference at Seminar of Ophthalmology. (University of Oviedo). Oviedo, Spain.

“Adalimumab in refractory uveitis: A multicenter sudy of 132 cases”. 29th Congress of the Pan-American Association of Ophthalmology. Buenos Aires, Argentina.

“Adalimumab in peripheral ulcerative keratitis”. Miguel Cordero Coma, et al. 87th Meeting of the Spanish Society of Ophthalmology (S.E.O.). Madrid, Spain.

“Screening of antiretinal antibodies in idiopathic or refractory posterior segment uveitides”. Rodríguez E, Cordero Coma M, et al. 87th Meeting of the Spanish Society of Ophthalmology (S.E.O.). Madrid, Spain.

“A Cost-effectiveness Analysis of Off-label Biologics to Treat Sarcoid Posterior Uveitis Versus Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic Steroids”. Padula. WV, Cordero-Coma M, Yilmaz T. The 33rd Annual Meeting of the Society for Medical Decision Making. Chigago, USA.

“A Cost-effectiveness Analysis of Off-label Biologics to Treat Sarcoid Posterior Uveitis Versus Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic Steroids”. Padula. WV, Cordero-Coma M, Yilmaz T. International Society of Pharmacoeconomics and Outcomes Research, Annual European Congress, Madrid, Spain.

“High dose intravenous methylprednisolone induces rapid improvement in severe uveitis: A multicenter study”. Bejerano C, Blanco R, Beltrán E, Fonollosa A, Maiz O, Blanco A, Cordero-Coma M, et al. 75th Meeting of the American College of Rheumatology, Chicago, USA.

“Adalmumab in 107 refractory uveitis: A multicenter study”. Pompei O, Blanco R, Díaz-llopis M, Salom D, García de Vicuña C, Cordero-Coma M, et al. 75th Meeting of the American College of Rheumatology, Chicago, USA.

“High dose intravenous methylprednisolone induces rapid improvement in severe uveitis: A multicenter study”. Bejerano C, Blanco R, Beltrán E, Fonollosa A, Maiz O, Blanco A, Cordero-Coma M, et al. 75th Meeting of the American College of Rheumatology, Chicago, USA.

“Adalmumab in 107 refractory uveitis: A multicenter study”. Pompei O, Blanco R, Díaz-llopis M, Salom D, García de Vicuña C, Cordero-Coma M, et al. 75th Meeting of the American College of Rheumatology, Chicago, USA.

“Pathogenesis of uveitic glaucoma”. Lecture. 11th International Ocular Inflammation Society Congress and International Assembly of Ocular Inflammation Societies. Goa, India.

2012

“High dose intravenous Methylprednisolone Induces Rapid Improvement In Severe Uveitis: A Multicenter Study”. Cordero Coma M. Meeting of the Association for Research in vision and Ophthalmology (ARVO). 2012. FortLauderdale, Fl (USA).

“Spanish study for Ocular Syphilis”. Artaraz J, Spanish study for Ocular Syphilis (SOS)-group. Meeting of the Association for Research in vision and Ophthalmology (ARVO). 2012. FortLauderdale, Fl (USA)

“Ocular toxocariasis: The value of serology”. Martín-Escuer B, Cordero-Coma M. 25th Meeting of the Spanish Uveitis Society (SEDU/GEMU).Valencia, Spain, February 2012. Valencia, Spain

“Interferon alpha 2A and Behçet disease”. Rodríguez Domingo E, Cordero Coma M. 25th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia, Spain

“Cylophosphamide and intravenous immunoglobuins in Susac´s syndrome”. Lopez Mancilla R, Cordero Coma M . 25th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia, Spain

“Adalimumab specifically induces t-regulatory cells and decreased vascular endothelial growth factor serum levels in refractory immuno-mediated uveitis”. Llorente M, Calleja S, Rodríguez E, Cordero Coma M. 8th Internatinal Congress on Autoimmunity. Granada, Spain

Antiretinal antibodies in chronic immuno-mediated posterior uveitis”. Llorente M, Rodríguez E, Cordero-Coma M. 8th International Congress on Autoimmunity. Granada, Spain

Syphilitic uveitis: a multicenter study of 50 cases”. Pérez-Martín I, Blanco R, Fonollosa, Sorribas M, Díaz-Valle D, Adán A, Llorens Distefano L, Cordero M, et al. 2012 European League Against Rheumatism (EULAR) meeting. Berlin, Germany.

Adalimumab therapy in 40 patients with refractory juvenile idiopathic arthritis-associated uveitis: a multicenter study”. J. Loricera, V. Calvo-Río, M. Díaz-Llopis, D. Salom, C. García-Vicuña, M. Cordero-Coma. 2012 European League Against Rheumatism (EULAR) meeting. Berlin, Germany

“Other biologic agents for the treatment of uveitis”. Cordero Coma M. Uveitis subspeciality day. 88th Meeting of the Spanish Society of Ophthalmology (S.E.O.). Barcelona, Spain

“Prevalence of Spondyloarthritis in Anterior Uveitis Patients: The SENTINEL Study”. Cordero Coma M. 76th Meeting of the American College of Rheumatology, Washington, USA

“Response to Adalimumab in 40 Patients with refractory juvenile Idiopathic Arthritis-Associated Uveitis. A Multicenter Study”. Vanesa Calvo-Rio, Ricardo Blanco, Manuel Dıaz-Llopis, David Salom, Carmen García-Vicuña, Miguel Cordero-Coma. 76th Meeting of the American College of Rheumatology, Chicago, USA.

2013

“Role of the CD-4/CD-8 ratio in vitreous fluid in the diagnosis of sarcoid uveitis”. Martín Escuer, Cordero Coma M, et al. 26th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia, Spain.

“Dexamethasone intravitreal implant (Ozurdex®) in the management of non-infectious uveitis: Main indications”. Garzo I, Cordero Coma M. 26th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia, Spain, 2013.

“Multicenter study of tumour necrosis factor alpha antagonists for refractory Behçet’s uveitis in Spain”. Marina Mesquida, María Victoria Hernández, David Díaz-Valle, Miguel Cordero, et al. Meeting of the Association for Research in vision and Ophthalmology (ARVO). 2013. Seattle (USA).

“Treatment with tuberculostatics of presumed tuberculous non-anterior uveitis: Long-term results”. Cordero Coma M. XXI Meeting of the Panamerican Association of Ophthalmology/Spanish Society of Ophthalmology. Santiago de Compostela, Spain.

“Mechanisms of immune-modulation of anti-TNF drugs for treatment of non-infectious uveitis”. Cordero Coma M. XXI Meeting of the Panamerican Association of Ophthalmology/Spanish Society of Ophthalmology. Santiago de Compostela, Spain.

“Bilateral herpetic keratouveitis in immunocompetent patients”. Martín Escuer B, Cordero Coma M. 89th Meeting of the Spanish Society of Ophthalmology (S.E.O.). Tenerife, Spain.

“Intravitreal dexamethasone implant (Ozurdex®) in AIJ-associated uveitic cataract surgery”. Garzo García I, Cordero Coma M. 89th Meeting of the Spanish Society of Ophthalmology (S.E.O.). Tenerife, Spain 2013.

“Short and long-term biological therapy in refractory uveitis of Behcet’s syndrome. Multicenter study of 124 patients”. Calvo-Río, Vanesa; Blanco, Ricardo; Beltrán, Emma; Sánchez-Bursón, Juan ; Mesquida, Marina; Adan, Alfredo M.; Hernandez Grafella, M ; Valls Pascual, E ; Martínez-Costa, L ; Sellas-Fernàndez, Agustí ; Cordero-Coma, Miguel, et al. 77th Meeting of the American College of Rheumatology, San Diego, Ca, USA, 2013.

“Biologic Therapy In Refractory Uveitis Of Behcet’s Syndrome: Switching and Dose Modification. Multicenter Study Of 124 Patients”. Calvo-Río, Vanesa; Blanco, Ricardo; Beltrán, Emma; Sánchez-Bursón, Juan ; Mesquida Marina; Adan, Alfredo M.; Hernandez Grafella, M ; Valls Pascual, E ; Martínez-Costa, L ; Sellas-Fernàndez, A ; Cordero-Coma, Miguel. 77th Meeting of the American College of Rheumatology, San Diego, Ca, USA,

“Biologic therapy in refractory uveitis of sarcoidosis. Multicenter study of 16 patients”. Calvo-Río V, Blanco R, Mesquida M, Adán A, Herreras JM, Aparicio A, Moreno Ramos MJ, Moreno Martínez MJ, Linares Ferrando LF, Hernández Martínez M, Peitado López D, Cordero Coma M, et al. 77th Meeting of the American College of Rheumatology, San Diego, Ca, USA,

“Prevalence of Spondyloarthritis in Anterior Uveitis Patients: The SENTINEL Study”. Cordero Coma M. Meeting of the American Academy of Ophthalmology (AAO). New Orleans, Lo (USA).

“Anti-TNF therapy in uveitis”. M Cordero. VII Congress of the AADEA. Almería, Spain.

2014

“Macular ischemia in posterior uveitis”. López Valverde G, Cordero Coma M, et al. 27th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia, Spain, 2014.

“ExPRESS implant for Posner-Schlossman syndrome”. Costales Mier F, Cordero Coma M, et al. 27th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia, Spain.

“ExPRESS implant for Posner-Schlossman syndrome”. Costales Mier F, Cordero Coma M, et al. 9th Meeting of the Spanish Glaucoma Society. Murcia, Spain.

“White dots syndrome”. Monje Fernández L, Cordero Coma M, et al. 27th Meeting of the Spanish Uveitis Society (SEDU/GEMU). Valencia, Spain.

“Golimumab in uveitis refractory to other anti-TNF agents: Multicenter study of 14 patients”. Ortiz-Sanjuan F, Blanco R, Cañal J, Cordero-Coma M, et al. 40th meeting of the Spanish Society of Rheumatology. Santiago Compostela, Spain.

“Comparative study of infliximab vs adalimumab in patients with refractory uveitis associated to Behcet’s disease: Multicenter study of 125 cases”. Beltrán Catalán E, Calvo-Rio V, Rodríguez Cundín P, Cordero-Coma M, et al. 40th meeting of the Spanish Society of Rheumatology. Santiago Compostela, Spain.

“Anti-TNF therapy in refractory sarcoid uveitis: Multicenter study of 16 cases”. Santos-Gómez M, Calvo-Rio V, Blanco R, Cordero Coma M, et al. 40th meeting of the Spanish Society of Rheumatology. Santiago Compostela, Spain.

“Uveitis refractory to infliximab and/or adalimumab in Behcet’s disease: Efficacy of other biologic therapies”. Santos-Gómez M, Calvo-Rio V, Beltrán-Catalán E, Blanco R, Mesquida M, Adán A, Cordero-Coma M, et al. 40th meeting of the Spanish Society of Rheumatology. Santiago Compostela, Spain.

“Induction therapy with endovenous methylprednisolone in serious ocular inflammation: A multicentre study”. Beltrán-Catalán E, Calvo-Rio V, Blanco R, Cordero-Coma M, et al. 40th meeting of the Spanish Society of Rheumatology. Santiago Compostela

Multidisciplinary management of the patient with spondyloarthritis: Ophthalmologists ́point of view”. Cordero-Coma M. 40th meeting of the Spanish Society of Rheumatology. Santiago Compostela, Spain,

Publicaciones

2006

Cordero Coma M., Sobrin L., Foster CS. “Sympathetic Ophthalmia” . Contemp Ophthalmol 2006; 5 (5).

2007

Cordero Coma M., Anzaar F., Sobrin L., Foster CS. “Systemic Immunosuppressive Therapy in Dry Eye Secondary to Dacryoadenitis” . Ocul Immunol Inflamm 2007 Mar-Apr;15(2):99-104.

Cordero Coma M., Anzaar F., Yilmaz T., Foster CS. “Herpetic Retinitis”. Herpes. 2007 Jun;14(1):4-10.

Cordero Coma M., Yilmaz T, Foster CS. “Tumor Necrosis Factor-alpha in Conjunctiva affected by Ocular Cicatricial Pemphigoid” . Acta Ophthalmol Scand. 2007 Nov;85(7):753-5.

Cordero Coma M., Sobrin L., Onal S., Christen W., Foster CS. “Intravitreal Bevacizumab for Uveitic Macular Edema”.Ophthalmology. 2007 Aug;114(8):1574-1579.

2008

Cordero-Coma M, Benito MF, Hernández AM, Antolín SC, Ruíz JM.”Serpiginous choroiditis” . Ophthalmology. 2008 Sep;115(9):1633, 1633.e1-2.

2009

Yilmaz T, Moyer B, Mc Donell RE, Cordero-Coma M, et al. “Outbreaks associated with unpasteurized milk and soft cheese: An overview of consumer safety”. Food Protection Trends. 2009;29(4):211-222.

Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, et al. “Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema”. Ophthalmology. 2009 May;116(5):902-11; Ophthalmology. 2009.

Cordero-Coma M, Calleja S,Torres HE, del Barrio I, Franco M, T Yilmaz, S Vivas, JGR de Morales. “The value of an immune response to Mycobacterium tuberculosis in patients with chronic posterior uveitides revisited: utility of the new IGRAs” . Eye. 2009. In press.

2010

Cordero-Coma M, Benito MF, Lobato C, Antolín SC, Ruíz JM. “Adalimumab for Mooren ́s ulcer”. Ophthalmology. 2009 Aug;116(8):1589, 1589.

Cordero-Coma M, Franco-Benito M, García-Ruiz-de-Morales JM, Alonso-Orcajo N, Del Barrio-Manso I. “Succesful treatment of surgically induced necrotizing sclerokeratitis (SINS) with systemic immunosuppressive agents and amniotic membrane grafting”. Arch Soc Esp Oftalmol. 2009 Nov;84(11):577-80.

Yilmaz T, Cordero-Coma M, et al. “Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema”. Acta Ophthalmol. 2010 Jul 20.

Cordero-Coma M, et al. “Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema”. Graefes Arch Clin Exp Ophthalmol. 2011 Jul;249(7):1103-5.

Yilmaz T, Cordero-Coma M, et al. “Triamcinolone and intraocular sustained-release delivery systems in diabetic retinopathy” . Curr Pharm Biotechnol. 2011 Mar 1;12(3):337-46.

Del Barrio-Manso I, Toribio-García A, Cordero-Coma M, et al. “Creutzfeldt – Jakob presenting with isolated visual symptoms: the Heidenhain variant” . Arch Soc Esp Oftalmol. 2010 Oct;85(10):341-4.

Cordero-Coma M, et al. “Toxoplasmic retinochoroiditis: relapse vschoroidal neovascular membrane” . Arch Soc Esp Oftalmol. 2010 Dec;85(12):410-3.

2011

Yilmaz T, Cordero Coma M, et al. “Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema”. Expert Opin Drug Metab Toxicol. 2011 Jul 27.

Cordero Coma M, et al. “Adjunctive globe magnetic resonance imaging in the diagnosis of posterior scleritis”. Can J Ophthalmol. 2011 Aug;46(4):329-32.

Cordero Coma M, et al. ”Golimumab for uveitis”. Ophthalmology 2011 Sep;118(9):1892.

Salazar R, Cordero Coma M. “Serpiginous choroiditis: Activityindices”. Studium Ophthalmologicum – Vol. XXIX – N.o 1 – 2011: 9-16

2012

Yilmaz T, Cordero Coma M, et al. “Ketorolac therapy for the prevention of acute pseudophakic macular edema: A systematic review”. Eye (Lond). 2012 Feb;26(2):252-8.

Calleja S, Cordero-Coma M, Rodriguez E, Llorente M, Franco M, Ruiz de Morales JG. “Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study.” Eye (Lond). 2012 Mar;26(3):468-77.

Díaz-Llopis M, Salom D, Garcia-de-Vicuña C, Cordero-Coma M, Ortega G, Ortego N, Suarez-de-Figueroa M, Rio-Pardo MJ, Fernandez-Cid C, Fonollosa A, Blanco R, Garcia-Aparicio AM, Benitez-Del-Castillo JM, Olea JL, Arevalo JF. “Treatment of Refractory Uveitis with Adalimumab: “A Prospective Multicenter Study of 131 Patients” .Ophthalmology. 2012 Aug;119(8):1575-81.

Yilmaz T, Cordero-Coma M. “Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review” . Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):787-93.

Cordero-Coma M, Pérez-Moreiras JV, Toribio A, Alonso-Orcajo N, Calleja S, Franco M, Ruiz de Morales JG. “Refractory Pyoderma Gangrenosum of the Orbit and the Lacrimal Sac” . Orbit. 2012 May 9.

JM.“Adalimumab for refractory peripheral ulcerative keratitis”. J Ophthalmic Inflamm Infect. 2012

Toribio García JA, Pérez Díez E, Cordero Coma M, et al.“Ophthalmological attitude in rhino-orbital mucormycosis: A propos of a case”. Span J Ophthal Res. 2012 2 (4):245-7.

Cordero-Coma M, Méndez RS, Blanco AC, Corral AL, Calleja-Antolín S, de Morales JM.“Adalimumab for refractory peripheral ulcerative keratitis”. J Ophthalmic Inflamm Infect. 2012

2013

Cordero-Coma M, Yilmaz T, Onal S. “Systematic review of of Anti-Tumor Necrosis Factor-alpha Therapy for Treatment of Immune-mediated Uveitis”. Ocul Immunol Inflamm. 2013 Feb;21(1):12-20.

Cervantes-Castañeda RA, Gonzalez-Gonzalez LA, Cordero Coma M, Yilmaz T, Foster CS. “Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: a 12-month follow-up” . Br J Ophthalmol. 2013 May;97(5):637-43.

Lavaque AJ, Yilmaz T, Cordero-Coma M. “Localized bi-nasal macular edema in optic chiasmal syndrome” . Indian J Ophthalmol. 2013 Jul;61(7):351-3.

Cénit MC, Márquez A, Cordero-Coma M, et al. “Lack of association between the protein tyrosine phosphatase non-receptor type 22 r263q and r620w functional genetic variants and endogenous non-anterior uveitis”. Mol Vis. 2013;19:638-43.

Cordero Coma M, Calleja S, Rodriguez E, Llorente M, Franco M, Ruiz de Morales JG. “Serum cytokine profile in adalimumab-treated refractory uveitis patients: Decreased IL-22 correlates with clinical responses”. Ocul Immunol Inflamm. 2013 Jun;21(3):212-9.

Cordero-Coma M, Garzo I, Salazar R, Franco M, Calleja S, Ruíz de Morales JM. “Treatment of presumed tuberculous uveitides affecting the posterior segment: Diagnostic confirmation and long term outcomes”. Arch Soc Esp Oftalmol. 2013 Sep;88(9):339-44.

“Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition”. Cénit MC, Márquez A, Cordero-Coma M, et al. BMC Med Genet. 2013 May 15;14:52.

“Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis” . Márquez A, Cénit MC, Cordero-Coma M, et al. PLoS One. 2013 Oct 7;8(10):e76777.

“Preoperative cataract surgery use of an intravitreal dexamethasone implant (Ozurdex) in a patient with juvenile idiopathic arthritis and chronic anterior uveitis”. J AAPOS. 2013 Dec;17(6):632-4.

“Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis”. Garcia-de-Vicuña C, Diaz-llopis M, Salom D, Bou R, Díaz-Cascajosa J, Cordero-Coma M. Mediators of inflammation 2013 (in Press).

“No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis “.Márquez A, Cénit MC, Cordero-Coma M, et al. PLoS One. 2013 Nov 29;8(11):e72892.

2014

“Tuberculous uveitis: An update”. Expert Rev. Ophthalmol. 2014 (in press)

“Bilateral herpetic keratouveitis in an immune competent patient”. Martín Escuer B, Cordero Coma M, et al. Arch Soc Esp Oftalmol. 2014 (in press).

“Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience”. Cordero-Coma M et al. Mediators of Inflammation 2014, (in Press).

Publicaciones Online

2006

“Choroidal neovascularization in sympathetic ophthalmia”. Sobrin L, Cordero Coma M, Foster CS. “Uveitis.org”. Vol.IX No. May 2006

“Contact lenses abuser-“. Cordero Coma M. Clinical case presentation. “Oculotest.com” .1st E-learning Plattform of continuous education in Ophthalmology.

“Problems after Pterygium surgery”. Cordero Coma M. Clinical case presentation. “Oculotest.com” .1st E-learning Plattform of continuous education in Ophthalmology.

“Bilateral long-term keratopathy”. Cordero Coma M. Clinical case presentation. “Oculotest.com” .1st E-learning Plattform of continuous education in Ophthalmology.

“Rash, Fever, and red eye in a previous healthy child”. Cordero Coma M. Clinical case presentation. “Oculotest.com” .1st E-learning Plattform of continuous education in Ophthalmology.

“Corneal ulceration and hypopion in a patient with P.U.K.”. Cordero Coma M. Clinical case presentation. “Oculotest.com” .1st E-learning Plattform of continuous education in Ophthalmology.

Libros

2007

Yilmaz T, Cordero-Coma M, Cervantes-Castañeda R, Foster CS. Atlas of Ocular Inflammatory Diseases. The Ocular Immunology and Uveitis Foundation.

2012

Adán A, Cordero Coma M, et al. Advances in diagnosis and treatment of intraocular infections. Spanish Society of Ophthalmology.

2013

Management of the uveitic macular edema. Guides for clinical practice of the Spanish Society of Retina-Vitreous (SERV).

Capítulos en Libros

2007

Foster CS, Cordero Coma M, Streilein JW. “Immune MediatedTissue Injury” in: Albert DM, Jakobiec FA. “Principles and Practice of Ophthalmology“. Saunders. New Edition

2011

Cordero Coma M, Ruíz de Morales JG. “Real value of lab-working”in: Uveitis: Diagnostic protocols and new therapeutic strategies. GEMU-SEDU.

Ruíz de Morales JG, Cordero Coma M. “Why anti-TNF therapyin autoimmune uveitis” in: Uveitis: Diagnostic protocols and new therapeutic strategies. GEMU-SEDU.

Cordero Coma M, Díaz Llopis M. “Immunosuppressive strategyin special situations”. in: Uveitis: Diagnostic protocols and new therapeutic strategies. GEMU-SEDU.

2012

Cordero Coma M. “Vogt Koyanagi Harada and SympatheticOphthalmia”, in: Adán A. “Treatment of uveitis with anti-TNFα drugs”. Elsevier-Doyma.

2013

Cordero Coma M, Salazar Méndez R. “Validation of diagnostictests”, in: Beneyto P “Clinical research manual”. Spanish Society of Ophthalmology.

2014

Cordero Coma M, Salazar R. “Interferons”, in: Mesquida M “Advances in the treatment of non-infectious uveitis with biologics: Anti-TNF and beyond”. OMICS group.

Cordero Coma M, Salazar R. “Intermediate uveitis”, in: Portero A,Carreño E “Immunomodulators and antiinflamatory therapy: beyond corticosteroid therapy”. Spanish Society of Ophthalmology.

Awards

2011

Best paper in Ocular Inflammation. 29th Congress of the Pan-American Association of Ophthalmology. (Ir a la web)

Puedes contactar con nuestro equipo

Pide Cita